HAVCR2 and non-small cell lung carcinoma: TIM-3 (CD366 or HAVCR2) is expressed on highly dysfunctional T cells, and TIM-3-associated drug resistance has been observed in HNSCC and non-small-cell lung cancer (NSCLC) (46, 47).